| For: | Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol 2014; 6(6): 384-393 [PMID: 25018849 DOI: 10.4254/wjh.v6.i6.384] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/384.htm |
| Number | Citing Articles |
| 1 |
Jemal Alemu, Balako Gumi, Aster Tsegaye, Abdulaziz Abubeker, Fisihatsion Tadesse, Abel Shewaye, Ziyada Rahimeto, Adane Mihret, Andargachew Mulu, Amha Gebremedhin, Rawleigh Howe. Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study. Infectious Agents and Cancer 2023; 18(1) doi: 10.1186/s13027-023-00519-6
|
| 2 |
Jose Ignacio Vargas, Daniela Jensen, Valeska Sarmiento, Felipe Peirano, Pedro Acuña, Felipe Fuster, Sabrina Soto, Rodrigo Ahumada, Marco Huilcaman, Mario Bruna, Werner Jensen, Francisco Fuster. Presence of anti‐HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile. Journal of Medical Virology 2016; 88(4) doi: 10.1002/jmv.24384
|
| 3 |
Mohammad Hossein Ahmadi, Zohreh Sharifi, Ali Ghasemi, Sadegh Abbasian. Occult hepatitis B in Iranian blood donors, an overview of the challenges: A narrative review. Health Science Reports 2023; 6(8) doi: 10.1002/hsr2.1466
|
| 4 |
Jiaying Wu, Jiayao He, Hongmei Xu. Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis. Annals of Hepatology 2024; 29(1) doi: 10.1016/j.aohep.2023.101158
|
| 5 |
Nicola Coppola, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Italo F. Angelillo. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease. Medicine 2016; 95(30) doi: 10.1097/MD.0000000000004311
|
| 6 |
H. Wang, R. Swann, E. Thomas, H. A. Innes, H. Valerio, P. C. Hayes, S. Allen, S. T. Barclay, D. Wilks, R. Fox, D. Bhattacharyya, N. Kennedy, J. Morris, A. Fraser, A. J. Stanley, R. Gunson, P. G. Mclntyre, A. Hunt, S. J. Hutchinson, P. R. Mills, J. F. Dillon. Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis. Journal of Viral Hepatitis 2018; 25(8) doi: 10.1111/jvh.12897
|
| 7 |
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, Nicola Coppola. Prevalence of occult HBV infection in Western countries. Journal of Medical Virology 2020; 92(12) doi: 10.1002/jmv.25867
|
| 8 |
Claudia Bozza, Marika Cinausero, Donatella Iacono, Fabio Puglisi. Hepatitis B and cancer: A practical guide for the oncologist. Critical Reviews in Oncology/Hematology 2016; 98 doi: 10.1016/j.critrevonc.2015.10.017
|
| 9 |
A. Marrone, N. Capoluongo, C. D'Amore, M. Pisaturo, M. Esposito, S. Guastafierro, I. Siniscalchi, M. Macera, A. Boemio, L. Onorato, L. Rinaldi, C. Minichini, L. E. Adinolfi, E. Sagnelli, L. Mastrullo, N. Coppola. Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy. Journal of Viral Hepatitis 2018; 25(2) doi: 10.1111/jvh.12802
|
| 10 |
Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, Nicola Coppola. Management of HBV reactivation in non-oncological patients. Expert Review of Anti-infective Therapy 2018; 16(8) doi: 10.1080/14787210.2018.1505501
|
| 11 |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
|
| 12 |
Evangelista Sagnelli, Loredana Alessio, Caterina Sagnelli, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Margherita Macera, Gaetano Scotto, Nicola Coppola. Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepatitis Monthly 2017; 17(8) doi: 10.5812/hepatmon.13260
|
| 13 |
Anna Felis-Giemza, Marzena Olesińska, Katarzyna Świerkocka, Ewa Więsik-Szewczyk, Ewa Haładyj. Treatment of rheumatic diseases and hepatitis B virus coinfection. Rheumatology International 2015; 35(3) doi: 10.1007/s00296-014-3195-8
|
| 14 |
Junichi Muraishi, Michihiko Shibata, Yuichi Honma, Masaaki Hiura, Shintaro Abe, Masaru Harada. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma. Internal Medicine 2017; 56(15) doi: 10.2169/internalmedicine.56.8233
|
| 15 |
Fujiko Mitsumoto-Kaseida, Masayuki Murata, Koji Takayama, Kazuhiro Toyoda, Eiichi Ogawa, Norihiro Furusyo, Jun Hayashi. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients. Journal of Infection and Chemotherapy 2020; 26(1) doi: 10.1016/j.jiac.2019.06.003
|
| 16 |
Bahiddin Yilmaz, Dilek Erdem, Fatih Teker, Ibrahim Goren, Beytullah Yildirim, Engin Kut, Derya Sarikaya, Memis H Atay, Idris Yucel. The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours. Journal of International Medical Research 2016; 44(3) doi: 10.1177/0300060516638992
|
| 17 |
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, Mariantonietta Pisaturo, Loredana Alessio, Stefania De Pascalis, Evangelista Sagnelli, Nicola Coppola. COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature. Pathogens 2022; 11(7) doi: 10.3390/pathogens11070816
|
| 18 |
Diana Gabriela Iacob, Monica Luminos, Otilia Elisabeta Benea, Ana-Maria Tudor, Cristina Mihaela Olariu, Simona Alexandra Iacob, Simona Ruta. Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.888050
|
| 19 |
Rosalia Lira, Ma Teresa Alvarez-Muñoz, Karina Enriquez-Navarro, Othon Rojas-Montes, Ana Maria Cevallos, Angelica Maldonado-Rodriguez. Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance. World Journal of Hepatology 2015; 7(2): 253-260 doi: 10.4254/wjh.v7.i2.253
|
| 20 |
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak, Sanjaya K Satapathy. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World Journal of Hepatology 2018; 10(3): 352-370 doi: 10.4254/wjh.v10.i3.352
|
| 21 |
K. C. K. Lau, C. Osiowy, E. Giles, B. Lusina, G. van Marle, K. W. Burak, C. S. Coffin. Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐HBV prophylaxis. Journal of Viral Hepatitis 2018; 25(6) doi: 10.1111/jvh.12860
|
| 22 |
Caterina Sagnelli, Massimo Ciccozzi, Loredana Alessio, Eleonora Cella, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Mara Capoprese, Laura Occhiello, Silvia Angeletti, Gaetano Scotto, Margherita Macera, Evangelista Sagnelli, Nicola Coppola. HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection 2018; 46(4) doi: 10.1007/s15010-018-1153-1
|
| 23 |
M. N Kornienko, T. N Rybalkina, N. V Karazhas, G. Yu Nikitina, M. Yu Kalugina, L. V Yarosh, T. A Semenenko. Identification of markers of opportunistic infections and viral hepatitis in oncohematological patients. Epidemiology and Infectious Diseases 2015; 20(6) doi: 10.17816/EID40888
|
| 24 |
E. Ghrenassia, E. Mariotte, E. Azoulay. Annual Update in Intensive Care and Emergency Medicine 2018. Annual Update in Intensive Care and Emergency Medicine 2018; doi: 10.1007/978-3-319-73670-9_43
|
| 25 |
J.A. Cuenca-Gómez, J. Salas-Coronas, M.J. Soriano-Pérez, J. Vázquez-Villegas, A.B. Lozano-Serrano, M.T. Cabezas-Fernández. Viral hepatitis and immigration: A challenge for the healthcare system. Revista Clínica Española (English Edition) 2016; 216(5) doi: 10.1016/j.rceng.2016.02.002
|
| 26 |
Gabriele Fabbri, Ilaria Mastrorosa, Alessandra Vergori, Valentina Mazzotta, Carmela Pinnetti, Susanna Grisetti, Mauro Zaccarelli, Adriana Ammassari, Andrea Antinori. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2287-y
|
| 27 |
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment. Journal of Viral Hepatitis 2016; 23(12) doi: 10.1111/jvh.12583
|
| 28 |
Yu. O. Ostankova, A. V. Semenov, E. B. Zueva, A. A. Totolian. THE PREVALENCE OF OCCULT HEPATITIS B AMONG HBSAG-NEGATIVE PERSONS WITH HIV IN VELIKY NOVGOROD. HIV Infection and Immunosuppressive Disorders 2019; 11(1) doi: 10.22328/2077-9828-2019-11-1-64-70
|
| 29 |
Edina Amponsah‐Dacosta, Selokela G. Selabe, Maphahlaganye J. Mphahlele. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co‐infected patients. Journal of Medical Virology 2018; 90(2) doi: 10.1002/jmv.24956
|
| 30 |
J.A. Cuenca-Gómez, J. Salas-Coronas, M.J. Soriano-Pérez, J. Vázquez-Villegas, A.B. Lozano-Serrano, M.T. Cabezas-Fernández. Hepatitis virales e inmigración: un reto para el sistema sanitario. Revista Clínica Española 2016; 216(5) doi: 10.1016/j.rce.2016.02.005
|
| 31 |
Awa Abdul Carimo, Eduardo Samo Gudo, Cremildo Maueia, Nédio Mabunda, Lúcia Chambal, Adolfo Vubil, Ana Flora, Francisco Antunes, Nilesh Bhatt, Pierre Roques. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique. PLOS ONE 2018; 13(1) doi: 10.1371/journal.pone.0190775
|
| 32 |
D. Candotti, L. Boizeau, S. Laperche. Occult hepatitis B infection and transfusion-transmission risk. Transfusion Clinique et Biologique 2017; 24(3) doi: 10.1016/j.tracli.2017.06.014
|
| 33 |
Katrin Busch, Robert Thimme. Natural history of chronic hepatitis B virus infection. Medical Microbiology and Immunology 2015; 204(1) doi: 10.1007/s00430-014-0369-7
|
| 34 |
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, Paolo Chiodini, Nicola Coppola. An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta‐analysis. Journal of Viral Hepatitis 2020; 27(4) doi: 10.1111/jvh.13248
|
| 35 |
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola, E. Sagnelli. Occult HBV infection in the oncohematological setting. Infection 2016; 44(5) doi: 10.1007/s15010-016-0891-1
|
| 36 |
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 2020; 48(1) doi: 10.1007/s15010-019-01345-y
|
| 37 |
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro, G. Tosone. Prevention of hepatitis B virus infection: from the past to the future. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(6) doi: 10.1007/s10096-015-2341-x
|
| 38 |
Conrado Fernández Rodríguez, Jose Lázaro Pérez-Calle, Elisa Carrera Alonso, Elsa de la Fuente Briongos, Pilar López-Serrano. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy. World Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
|
| 39 |
Ali Mussa, Nor Hayati Ismail, Nazmul Huda Syed, Mustafa Talib, Alaa Siddig, Rosline Hassan, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim. Immune response to occult hepatitis B virus infection among hemodialysis patients: A review. The Microbe 2024; 5 doi: 10.1016/j.microb.2024.100176
|
| 40 |
Chengrong Huang, Hao Zhang, Jing Wang, Jianfei Li, Qian Liu, Qiyin Zong, Yunyun Zhang, Qin Wang, Qiang Zhou. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway. Open Life Sciences 2025; 20(1) doi: 10.1515/biol-2022-0951
|
| 41 |
Min-Sun Kwak, Yoon Jun Kim. Occult hepatitis B virus infection. World Journal of Hepatology 2014; 6(12): 860-869 doi: 10.4254/wjh.v6.i12.860
|
| 42 |
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitors. Antiviral Research 2020; 179 doi: 10.1016/j.antiviral.2020.104815
|
| 43 |
Evangelista Sagnelli, Caterina Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
|
| 44 |
Pranatharthi H. Chandrasekar, Miriam T. Levine. Occult Hepatitis B Virus Reactivation in a Seronegative Stem Cell Transplant Recipient. Infectious Diseases in Clinical Practice 2017; 25(2) doi: 10.1097/IPC.0000000000000472
|
| 45 |
Evangelista Sagnelli, Loredana Alessio, Caterina Sagnelli, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Margherita Macera, Gaetano Scotto, Nicola Coppola. Hepatitis B Virus Genotypes, Epidemiological Characteristics and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepatitis Monthly 2017; 17(9) doi: 10.5812/hepatmon.13740
|
| 46 |
Bulent Cakal, Alp Atasoy, Bilger Cavus, Mehves Poda, Mesut Bulakci, Mine Gulluoglu, Mehmet Demirci, Filiz Akyuz. Prevalence of Occult Hepatitis B Infection in Liver Biopsy Sample of Patients with Nonviral Liver Disease. Future Virology 2022; 17(10) doi: 10.2217/fvl-2021-0316
|
| 47 |
Caterina Sagnelli, Massimo Ciccozzi, Nicola Coppola, Carmine Minichini, Alessandra Lo Presti, Mario Starace, Loredana Alessio, Margherita Macera, Eleonora Cella, Luciano Gualdieri, Nunzio Caprio, Giuseppe Pasquale, Evangelista Sagnelli. Molecular diversity in irregular or refugee immigrant patients with HBV‐genotype‐E infection living in the metropolitan area of Naples. Journal of Medical Virology 2017; 89(6) doi: 10.1002/jmv.24724
|